Skip to content

A study to determine whether micro blood clot signals can predict recovery and future outcomes in patients with acute ischemic stroke.

A Prospective Observational Cohort Study to Predict Prognostic Value of Micro Emboli Signals in Patients with Acute Ischemic Stroke. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112745
Enrollment
96
Registered
2026-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I639- Cerebral infarction, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Pinky
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults more than equal to 18 years till 80 years of either sex with acute ischemic stroke presenting within 24 hour of symptom onset. At least one insonatable intracranial artery for TCD examination via transtemporal acoustic window.

Exclusion criteria

Exclusion criteria: Intracerebral bleed including intracranial hemorrhage Subarachnoid hemorrhage SAH traumatic brain injury and Cerebral venous thrombosis Patients with poor temporal bone acoustic windows preventing MES monitoring. Pre-stroke severe disability mRS more than 2 Major comorbidities affecting prognosis eg advanced malignancy end-stage heart failure with expected survival less than 3 months. Refusal or inability to provide consent.

Design outcomes

Primary

MeasureTime frame
Proportion of patients with poor functional outcome mRS more than equal to 3 according to MES presence and persistence. Timepoint: 3 months (90 7 days) after stroke onset/enrollment

Secondary

MeasureTime frame
Outcome 1 MES Persistence as Predictor of Recurrence. Association between persistent MES (detected up to 72 hours) and recurrent ischemic stroke. Outcome 2 MES Burden and Stroke Severity Association between MES burden and stroke severity measured using NIHSS. Outcome 3 MES Burden Across Treatment Groups Comparison of MES burden among IVT, EVT, IVT+EVT, and medical therapy groups. Outcome 4 MES Burden and TOAST Classification Association between MES burden and TOAST stroke subtype. Timepoint: Time Point secondary outcome 1 Within 3 months of enrollment. Time Point of secondary outcome 2 At baseline, discharge, and 3 months. Time Point of secondary outcome 3 During hospitalization baseline to 72 hours. Time Point of secondary outcome 4 From hospitalization baseline.

Countries

India

Contacts

Public ContactPinky

Hospital

jeyarajpandian@hotmail.com09592588138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026